The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Psoriatic Arthritis Therapeutics Drug Market Research Report 2025
Synopsis
Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin.
The global Psoriatic Arthritis Therapeutics Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics Drug.
Report Scope
The Psoriatic Arthritis Therapeutics Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis Therapeutics Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Therapeutics Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Janssen Biotech
Novartis
Amgen
CELGENE CORPORATION
Pfizer
Eli Lilly
UCB
Biogen
Bristol-Myers Squibb
Segment by Type
NF Inhibitors
Interleukin Inhibitors
PDE4 Inhibitors
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Psoriatic Arthritis Therapeutics Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Psoriatic Arthritis Therapeutics Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin.
The global Psoriatic Arthritis Therapeutics Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics Drug.
Report Scope
The Psoriatic Arthritis Therapeutics Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis Therapeutics Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Therapeutics Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Janssen Biotech
Novartis
Amgen
CELGENE CORPORATION
Pfizer
Eli Lilly
UCB
Biogen
Bristol-Myers Squibb
Segment by Type
NF Inhibitors
Interleukin Inhibitors
PDE4 Inhibitors
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Psoriatic Arthritis Therapeutics Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Psoriatic Arthritis Therapeutics Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Psoriatic Arthritis Therapeutics Drug Market Overview
1.1 Product Overview and Scope of Psoriatic Arthritis Therapeutics Drug
1.2 Psoriatic Arthritis Therapeutics Drug Segment by Type
1.2.1 Global Psoriatic Arthritis Therapeutics Drug Market Value Comparison by Type (2024-2030)
1.2.2 NF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 PDE4 Inhibitors
1.2.5 Others
1.3 Psoriatic Arthritis Therapeutics Drug Segment by Application
1.3.1 Global Psoriatic Arthritis Therapeutics Drug Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Psoriatic Arthritis Therapeutics Drug Market Size Estimates and Forecasts
1.4.1 Global Psoriatic Arthritis Therapeutics Drug Revenue 2019-2030
1.4.2 Global Psoriatic Arthritis Therapeutics Drug Sales 2019-2030
1.4.3 Global Psoriatic Arthritis Therapeutics Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Psoriatic Arthritis Therapeutics Drug Market Competition by Manufacturers
2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Psoriatic Arthritis Therapeutics Drug Average Price by Manufacturers (2019-2024)
2.4 Global Psoriatic Arthritis Therapeutics Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Product Type & Application
2.7 Psoriatic Arthritis Therapeutics Drug Market Competitive Situation and Trends
2.7.1 Psoriatic Arthritis Therapeutics Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Psoriatic Arthritis Therapeutics Drug Players Market Share by Revenue
2.7.3 Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Psoriatic Arthritis Therapeutics Drug Retrospective Market Scenario by Region
3.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Psoriatic Arthritis Therapeutics Drug Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2019-2030
3.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2019-2024
3.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2025-2030
3.3 Global Psoriatic Arthritis Therapeutics Drug Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2019-2030
3.3.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2019-2024
3.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2025-2030
3.4 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.4.1 North America Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.4.3 North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.5.1 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.5.3 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.7.1 Latin America Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.7.3 Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2030)
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2024)
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2025-2030)
4.1.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
4.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2030)
4.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2024)
4.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2025-2030)
4.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
4.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2030)
5.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2024)
5.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2025-2030)
5.1.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
5.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2030)
5.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2024)
5.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2025-2030)
5.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
5.3 Global Psoriatic Arthritis Therapeutics Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Janssen Biotech
6.2.1 Janssen Biotech Corporation Information
6.2.2 Janssen Biotech Description and Business Overview
6.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.2.5 Janssen Biotech Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 CELGENE CORPORATION
6.5.1 CELGENE CORPORATION Corporation Information
6.5.2 CELGENE CORPORATION Description and Business Overview
6.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.5.5 CELGENE CORPORATION Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.7.5 Eli Lilly Recent Developments/Updates
6.8 UCB
6.8.1 UCB Corporation Information
6.8.2 UCB Description and Business Overview
6.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 UCB Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.8.5 UCB Recent Developments/Updates
6.9 Biogen
6.9.1 Biogen Corporation Information
6.9.2 Biogen Description and Business Overview
6.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.9.5 Biogen Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psoriatic Arthritis Therapeutics Drug Industry Chain Analysis
7.2 Psoriatic Arthritis Therapeutics Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psoriatic Arthritis Therapeutics Drug Production Mode & Process
7.4 Psoriatic Arthritis Therapeutics Drug Sales and Marketing
7.4.1 Psoriatic Arthritis Therapeutics Drug Sales Channels
7.4.2 Psoriatic Arthritis Therapeutics Drug Distributors
7.5 Psoriatic Arthritis Therapeutics Drug Customers
8 Psoriatic Arthritis Therapeutics Drug Market Dynamics
8.1 Psoriatic Arthritis Therapeutics Drug Industry Trends
8.2 Psoriatic Arthritis Therapeutics Drug Market Drivers
8.3 Psoriatic Arthritis Therapeutics Drug Market Challenges
8.4 Psoriatic Arthritis Therapeutics Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
